Clinical standards - Faster Dignosis Standard

Clinical Review of Standards: Progress Update
NHS England / Improvement Board meeting 30 January 2020

• The paper notes the progress to date and the latest learning from the Clinically-led Review of NHS Access Standards, including cancer proposals.
• Initial testing during phase one focused on demonstrating that there is no detriment either to patients or overall operational performance in moving to the Faster Diagnosis Standard, with phase two focussing more specifically on the impact of interventions to improve 28-day performance. This review will make its final recommendations in respect of cancer in the spring of 2020.

Cerebral palsy in adults [Quality Standard]

Cerebral palsy in adults [QS191]
NICE Quality standard January 2020

The measurement maze

The measurement maze
Health Foundation November 2019

• This briefing takes a snapshot of national quality measures in three clinical areas with differing levels of national scrutiny – breast cancer, children and young people’s mental health (CYMPH), and renal care. 
• Supplementary reports include the identified  indicator lists (national-level quality indicators, local quality indicators and missing indicators) for each area.

Clinically-led Review of NHS Access Standards - progress report

Clinically-led Review of NHS Access Standards
NHS England 31 October 2019

• This is a progress report on the review of NHS access standards in urgent and emergency care, mental health services, cancer care and elective care. It
• 1. recaps on the proposed new standards in each of the four areas, the rationale for those proposals, and update on what we are finding through testing.
• 2. sets out the planned next steps in terms of continuing with testing and
• 3. outlines the timetable for making final recommendations and implementing any agreed new standards.
• "For urgent and emergency care, where the field testing has been running longer and will be able to conclude sooner, the intention is to support the NHS to implement any changes from 1 April 2020. For elective care and cancer, implementation is likely to be during mid 2020/21. In mental health, where completely new standards are being proposed, implementation will be to a longer timeframe, as testing is likely to continue in 2020/21 to ensure that the introduction of standards in these areas is sustainable. All timelines are subject to change and government agreement."

Specialised services quality dashboards update

Specialised services quality dashboards
NHS England 14 March 2019

• 2019/20 Metric Definitions sets have been published.

Pancreatic cancer Quality standard

Pancreatic cancer Quality standard [QS177]
NICE December 2018

• This quality standard covers diagnosis of pancreatic cancer and management of pancreatic ductal adenocarcinoma in adults aged over 18. 
• Quality statements
• Statement 1 Adults with suspected pancreatic cancer have their diagnosis and care agreed by a specialist pancreatic cancer multidisciplinary team (MDT).
• Statement 2 Adults with localised pancreatic cancer on CT have staging using fluorodeoxyglucose positron emission tomography/CT (FDG‑PET/CT) before they have surgery, radiotherapy or systemic therapy.
• Statement 3 Adults with resectable pancreatic cancer and obstructive jaundice have resectional surgery rather than preoperative biliary drainage unless the drainage is specifically indicated.
• Statement 4 Adults with unresectable pancreatic cancer are prescribed enteric-coated pancreatin.
• Statement 5 (placeholder) Effective interventions to address psychological needs.

Oesophago-gastric cancer Quality standard [QS176]

Oesophago-gastric cancer Quality standard [QS176]
NICE December 2018

• This quality standard covers assessing and managing oesophago-gastric cancer in adults. 
• Statement 1 Adults with oesophago-gastric cancer have access to an oesophago-gastric clinical nurse specialist.
• Statement 2 Adults with oesophago-gastric cancer have their treatment reviewed by a multidisciplinary team that includes an oncologist and a specialist radiologist who both have an interest in oesophago-gastric cancer.
• Statement 3 Adults with oesophageal or gastro-oesophageal junctional tumours (except T1a tumours) for whom radical treatment is suitable, have 18‑fluorodeoxyglucose positron emission tomography requested and reported within 1 week.
• Statement 4 Adults with oesophago-gastric cancer have tailored specialist dietetic support before and after radical treatment.

Cystic Fibrosis Quality Standard

Cycstic Fibrosis [QS168]
NICE Quality Standard May 2018

• This quality standard covers diagnosing and managing cystic fibrosis in infants, children, young people and adults

Parkinson's Disease – Quality Standard

Parkinson's Disease – Quality Standard
NICE February 2018

• Statement 1: Adults with Parkinson's disease have a point of contact with specialist services.
• Statement 2: Adults with Parkinson's disease taking dopaminergic therapy are given information about the risk of impulse control disorders, when starting treatment and at least annually.
• Statement 3: Adults with Parkinson's disease are referred to physiotherapy, occupational therapy or speech and language therapy if they have problems with balance, motor function, activities of daily living, communication, swallowing or saliva.
• Statement 4: Adults with Parkinson's disease who are in hospital or a care home take levodopa within 30 minutes of their individually prescribed administration time. 
• Statement 5: Services for adults with Parkinson's disease provide access to clozapine and patient monitoring for treating hallucinations and delusions.